Reclast (zoledronic acid) is an expensive drug used to treat Paget's disease and osteoporosis in women. It is less popular than comparable drugs. There are currently no generic alternatives to Reclast. The most common version of Reclast is covered by 98% of insurance plans at a co-pay of $60.00-$82.50, however, some pharmacy coupons or cash prices may be lower.

With the Patient Assistance Program from PAN Foundation, contact the program to see how they can financially help you out.